Atrial Fibrillation (Updating the 2006 Guideline) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With

[1]  J. Le Heuzey,et al.  A Short‐Term, Randomized, Double‐Blind, Parallel‐Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study , 2010, Journal of cardiovascular electrophysiology.

[2]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[3]  C. Tondo,et al.  Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[5]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[6]  V. Hasselblad,et al.  Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized, Controlled Trials , 2009, Circulation. Arrhythmia and electrophysiology.

[7]  S. Connolly,et al.  Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter , 2009, Circulation.

[8]  V. Hasselblad,et al.  Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. , 2009, Journal of the American College of Cardiology.

[9]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[10]  J. Lau,et al.  Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation , 2009, Annals of Internal Medicine.

[11]  David J Cohen,et al.  Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation , 2009, Circulation. Arrhythmia and electrophysiology.

[12]  Matthew R. Reynolds,et al.  Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses , 2009, Circulation. Arrhythmia and electrophysiology.

[13]  C. Grines,et al.  Combining antiplatelet and anticoagulant therapies. , 2009, Journal of the American College of Cardiology.

[14]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[15]  W. Pikto-Pietkiewicz.  [The effect of dronedarone on the frequency of cardiovascular events in patients with atrial fibrillation - ATHENA studies]. , 2009, Kardiologia polska.

[16]  D. Callans.  Apples and oranges: comparing antiarrhythmic drugs and catheter ablation for treatment of atrial fibrillation. , 2008, Circulation.

[17]  J. Ruskin,et al.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.

[18]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[19]  J. Davy,et al.  Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. , 2008, American heart journal.

[20]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[21]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[22]  John V. Wylie,et al.  Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. , 2008, Archives of internal medicine.

[23]  J. Ruskin,et al.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.

[24]  S. Laffite,et al.  Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. , 2007, Journal of the American College of Cardiology.

[25]  D. Lin,et al.  Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[26]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[27]  C. Tondo,et al.  Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular Function , 2006, Pacing and clinical electrophysiology : PACE.

[28]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[29]  C. Pandozi,et al.  Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study. , 2006, Journal of the American College of Cardiology.

[30]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[31]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[32]  Prashanthan Sanders,et al.  Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias , 2005, Journal of cardiovascular electrophysiology.

[33]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[34]  Claus Schmitt,et al.  Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies , 2005, Circulation.

[35]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[36]  V. Santinelli,et al.  Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria: safety, feasibility, and efficacy. , 2005, Journal of the American College of Cardiology.

[37]  A. De Simone,et al.  Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[38]  Douglas Packer,et al.  Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.

[39]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[40]  G. Breithardt,et al.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.

[41]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[42]  David O. Martin,et al.  Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. , 2004, Journal of the American College of Cardiology.

[43]  Burr Hall,et al.  Catheter Ablation for Paroxysmal Atrial Fibrillation: Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation , 2003, Circulation.

[44]  A. Capucci,et al.  Dronedarone for prevention of atrial fibrillation: a dose-ranging study. , 2003, European heart journal.

[45]  Ottavio Alfieri,et al.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.

[46]  M. Josephson,et al.  Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. , 2003, The American journal of cardiology.

[47]  Gabriele Vicedomini,et al.  Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia A New Anatomic Approach for Curing Atrial Fibrillation , 2000 .

[48]  J. Knottnerus,et al.  Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin , 1999, BMJ.

[49]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[50]  V. Barriales,et al.  Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. , 1999, American heart journal.

[51]  P. Petersen,et al.  Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. , 1999, Archives of internal medicine.

[52]  M. Josephson,et al.  Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation. , 1999, The American journal of cardiology.

[53]  E. Antman,et al.  Risk of Initiating Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients Admitted to a University Hospital , 1997, Annals of Internal Medicine.

[54]  P. Kligfield,et al.  Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation. , 1994, The American journal of cardiology.

[55]  C Warlow,et al.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[56]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[57]  D. Mark,et al.  Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. , 2010, American heart journal.

[58]  Antonio De Simone,et al.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.

[59]  G. Kay,et al.  Design and Implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) Clinical Trial , 2004, Journal of Interventional Cardiac Electrophysiology.

[60]  J. Reiffel.  Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues. , 2000, Current opinion in cardiology.

[61]  T. Binder,et al.  Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. , 1995, American heart journal.

[62]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[63]  S. Sandhu,et al.  Optimal sampling interval to estimate heart rate at rest and during exercise in atrial fibrillation. , 1989, The American journal of cardiology.

[64]  A. Lowenthal.  The European Stroke Prevention Study , 1988, Acta neurologica Belgica.